Rebound Therapeutics Corporation Completes $102.1 Million Sale to Integra LifeSciences Corporation
Represented Rebound Therapeutics Corporation in its $102.1 million acquisition by Integra LifeSciences Corporation (NAS: IART). Rebound is a rapidly-growing medical device company that is focused on developing innovative single-use disposable devices for access, imaging, and illumination during minimally invasive neurosurgical procedures. Integra is a world leader in medical technology, dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care.
"Integra has a strong track record of commercializing technologies and working with surgeons to advance surgical care,” said Jeff Valko, chief executive officer, Rebound Therapeutics. “Through its global neurosurgical sales team, we are looking forward to providing both surgeons and patients with greater access to our products.
